Microbiome Revalia Bio’s Quest to Replace Animal Models with Human OrgansBy adminFebruary 19, 20260 Greg Tietjen and Jenna DiRito benching an organ for perfusion. [Revalia Bio] Greg Tietjen, PhDCEO, Revalia Bio In recent years…
Microbiome With Gordian Bio’s In Vivo Platform, Pfizer Revamps Obesity Target DiscoveryBy adminJanuary 8, 20260 Credit: unoL / iStock / Getty Images Plus Drug development is in a preclinical testing predicament. With advances in artificial…
Microbiome “Smart” NK Cells: Senti Bio’s Logic-Gated Immunotherapy Strikes R/R AMLBy adminDecember 10, 20250 Credit: quantic69 / iStock / Getty Images Plus For more than two decades, Timothy Lu, MD, PhD, has been dedicated…
Longevity Patent filed for Immorta Bio’s new senolytic vaccineBy adminNovember 28, 20250 Bold new senolytic immunotherapy targets aging at its roots – with early data suggesting wide-reaching longevity and anti-cancer potential. Miami-based…
